Literature DB >> 1306480

Effect of the application of acetazolamide soaked contact lenses on intraocular pressure of rabbits.

A Temel1, H Kazokoglu.   

Abstract

Topical application of acetazolamide has no known effect on intraocular pressure (IOP). We tried to detect the hypotensive effect on IOP of acetazolamide soaked onto soft contact lenses (CL). We applied CLs soaked in either 1%, 3%, or 5% acetazolamide solution onto one eye of 29 rabbits while the contralateral eye served as a control. There was an average 32% reduction of IOP amongst all acetazolamide applied eyes, and an average 19% reduction of IOP amongst all control eyes. Amongst the 1% acetazolamide-CL applied eyes there was a mean 37% reduction of IOP, amongst the 3% acetazolamide-CL applied eyes a mean 36% reduction, amongst the 5% acetazolamide-CL applied a mean 30% reduction, and a mean 19% reduction in control eyes. The longest period of IOP reduction followed the application of 1% acetazolamide-CLs, probably owing to improved drug corneal penetration at this concentration. Our results reveal that the application of acetazolamide soaked soft CLs has a significant hypotensive effect on IOP in both the applied and contralateral control eyes of rabbits.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1306480     DOI: 10.1007/bf00161020

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  13 in total

1.  Local application of diamox; an experimental study of its effect on the intraocular pressure.

Authors:  R H FOSS
Journal:  Am J Ophthalmol       Date:  1955-03       Impact factor: 5.258

2.  Effect of a carbonic anhydrase inhibitor (diamox) on intra-ocular pressure of rabbits and cats.

Authors:  J GLOSTER; E S PERKINS
Journal:  Br J Ophthalmol       Date:  1955-11       Impact factor: 4.638

3.  Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report.

Authors:  B BECKER
Journal:  Am J Ophthalmol       Date:  1954-01       Impact factor: 5.258

4.  MK-927: a topically effective carbonic anhydrase inhibitor in patients.

Authors:  A M Bron; E A Lippa; H M Hofmann; B I Feicht; J G Royer; F L Brunner-Ferber; D L Panebianco; H A Von Denffer
Journal:  Arch Ophthalmol       Date:  1989-08

5.  MK-927, a topical carbonic anhydrase inhibitor. Dose response and reproducibility.

Authors:  J B Serle; J S Lustgarten; E A Lippa; C B Camras; D L Panebianco; S M Podos
Journal:  Arch Ophthalmol       Date:  1990-06

6.  MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors.

Authors:  E A Lippa; J S Schuman; E J Higginbotham; M A Kass; R N Weinreb; G L Skuta; D L Epstein; B Shaw; D J Holder; D A Deasy
Journal:  Ophthalmology       Date:  1991-03       Impact factor: 12.079

7.  Aminozolamide gel. A trial of a topical carbonic anhydrase inhibitor in ocular hypertension.

Authors:  R A Lewis; R D Schoenwald; C F Barfknecht; C D Phelps
Journal:  Arch Ophthalmol       Date:  1986-06

8.  Topical acetazolamide and methazolamide delivered by contact lenses.

Authors:  Z Friedman; R C Allen; S M Raph
Journal:  Arch Ophthalmol       Date:  1985-07

9.  Ethoxzolamide analogue gel. A topical carbonic anhydrase inhibitor.

Authors:  R A Lewis; R D Schoenwald; M G Eller; C F Barfknecht; C D Phelps
Journal:  Arch Ophthalmol       Date:  1984-12

10.  Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors.

Authors:  H F Edelhauser; T H Maren
Journal:  Arch Ophthalmol       Date:  1988-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.